Biofil Chemicals & Pharmaceuticals Ltd Share Price Today Live NSE/BSE

Investment Ratings

As per analysts rating in the last 6 months, the recommendation is to HOLD Biofil Chemicals

Master Rating:
Biofil Chemicals & Pharmaceuticals has an operating revenue of Rs. 36.54 Cr. on a trailing 12-month basis. An annual revenue growth of 22% is outstanding, Pre-tax margin of 5% is okay, ROE of 7% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 22 which is a POOR score indicating inconsistency in earnings, a RS Rating of 3 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 162 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Biofil Chemicals & Pharmaceuticals Ltd Forecast

Price Estimates

2,000(9.8%)

1,758(-3.5%)

1,590(-12.7%)

Ratings

Eps And Sales Estimates

Sales(Cr) EPS

Biofil Chemicals & Pharmaceuticals Ltd Synopsis

NSE-Medical-Ethical Drugs

Biofil Chemicals belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 35.75 Cr. and Equity Capital is Rs. 16.27 Cr. for the Year ended 31/03/2021. Biofil Chemicals & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 04/01/1985 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L24233MP1985PLC002709 and registration number is 002709.

Market Cap

INR 97.73 Cr
Sales

INR 36.54 Cr
Shares in Float

0.86 Cr
No of Funds

5 K

Yield

%
Book Value

6.06
U/D Vol Ratio

0.9

LTDebt/Equity

%
Alpha

-0.66
Beta

0.71

Biofil Chemicals & Pharmaceuticals Ltd Ownership

Owner Name	Jun-21	Mar-21	Dec-20
Promoters	46.82%	46.82%	46.82%
Mutual Funds	0%	0%	0.45%
Financial Institutions/ Banks	0.08%	0.08%	0.08%
Individual Investors	37.15%	35.73%	31.84%
Others	15.95%	17.37%	20.81%

Biofil Chemicals & Pharmaceuticals Ltd Management

Name	Designation
Mr. Ramesh Shah	Managing Director
Mr. Ketan Shah	Whole Time Director
Mr. Romil Shah	Non Executive Director
Mrs. Shaila Jain	Independent Director
Mr. Satish Beohar	Independent Director
Mr. Ashok Kumar Ramawat	Independent Director

Biofil Chemicals & Pharmaceuticals Ltd Financials

Standalone Consolidated

Quarterly P&L
Annual P&L
Cash Flow
Balance Sheet
Ratios

INDICATOR	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020
Oper Rev Qtr Cr	13.7379	5.3687	14.2387	3.192	16.0186
Operating Expenses Qtr Cr	13.3658	5.0358	13.8675	2.5813	15.1086
Operating Profit Qtr Cr	0.3721	0.3329	0.3712	0.6107	0.91
Depreciation Qtr Cr	0.103	0.103	0.1893	0.1087	0.1088
Interest Qtr Cr	0.0097	0.0097	-0.0851	0.0116	0.02
Tax Qtr Cr	0.0779	0.067	0.6776	0	0
Net Profit Qtr Cr	0.2126	0.1739	-0.4149	0.5125	0.9271

INDICATOR	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Total Revenue Annual Cr	36.5503	29.8617	23.2298	12.4607	13.5923
Operating Expenses Annual Cr	34.1513	27.8679	22.1061	11.4256	10.8346
Operating Profit Annual in Cr	1.5991	1.8223	1.0225	0.9344	2.6198
Depreciation Cr	0.4119	0.4083	0.3651	0.2963	0.2842
Interest Annual Cr	0.0681	0.1214	0.1603	0.1506	0.1631
Tax Annual Cr	0.6776	0.2569	0.116	0.1175	0.5162
Net Profit Annual Cr	1.2414	1.2072	0.4823	0.4707	1.7942

INDICATOR	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Cash from Operating Activity Annual Cr	1.1109	0.8932	1.2557	0.4635	0.7114
Cash from Investing Activity Annual Cr	-0.0961	-0.2067	-1.4125	-0.3786	-0.4776
Cash from Financing Annual Activity Cr	-0.8303	-0.5667	-0.0815	-0.0201	-0.105
Net Cash Flow Annual Cr	0.1845	0.1198	-0.2383	0.0648	0.1288

INDICATOR	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Total ShareHolders Funds Annual Cr	16.1291	14.8831	13.6497	13.1674	12.6966
Fixed Assets Annual Cr	9.7769	10.0926	10.2942	9.2468	9.1645
Total Non Current Assets Annual Cr	9.7769	10.0926	10.2942	9.2468	9.1645
Total Current Assets Annual Cr	23.4615	32.2721	13.9188	14.9079	12.676
Total Assets Annual Cr	33.2384	42.3647	24.213	24.1547	21.8405

INDICATOR	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Book Value Per Share Annual Rs	9.911	9.145	8.387	8.091	7.801
ROE Annual %	7.69	8.11	3.53	3.57	14.13
ROCE Annual %	12.05	10.65	5.55	5.61	19.48
Total Debt to Total Equity Annual	-	-	-	-	-
EBDIT Annual Margin %	6.71	6.71	4.85	8.37	20.49

Quarterly P&L
Annual P&L
Cash Flow
Balance Sheet
Ratios

INDICATOR	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr

INDICATOR	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr

INDICATOR	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr

INDICATOR	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr

INDICATOR	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual	-	-	-	-	-
EBDIT Annual Margin %

Biofil Chemicals & Pharmaceuticals Ltd Technicals

EMA & SMA

CURRENT PRICE

60.05 (1.61)

- Bullish Moving Averages 5
- Bearish Moving Averages 11

EMA

EMA SMA

20 Day

60.56
50 Day

62.35
100 Day

64.64
200 Day

68.86

Biofil Chemicals & Pharmaceuticals Ltd Resistance and support

59.84 PIVOT

First Resistance

60.87
Second Resistance

62.64
Third Resistance

63.67

First Support

58.07
Second Support

57.04
Third Support

55.27

RSI

46.78
MFI

35.27

MACD

-1.06
MACD signal line

-1.11

Biofil Chemicals & Pharmaceuticals Ltd Delivery and Volume

Period	NSE + BSE Volume Avg	NSE + BSE Delivery Volume Avg	NSE + BSE Delivery Volume %
Day	40,427	2,477,771	61.29%
Week	35,643	2,280,070	63.97%
1 Month	31,469	2,147,431	68.24%
6 Month	80,139	4,719,379	58.89%

Biofil Chemicals & Pharmaceuticals Ltd Price change analysis

-2.75

Over 1 month

Low High

54.45 64.95

-3.1

Over 3 month

Low High

54.45 75.55

-9.6

Over 6 months

Low High

54.45 92.15

-181.05

Over Year

Low High

54.45 356.1

Similar Stocks

Company Name	52 Week ()	Market Price ()	Volume
Hikal Ltd	742.00	511.00 (1.44%)	25288
Alembic Ltd	143.30	101.30 (1.25%)	25057
Marksans Pharma Ltd	97.50	57.00 (2.89%)	78538
Sun Pharmaceuticals Industries Ltd	850.00	768.55 (3.11%)	520895

News

BIOFIL CHEMICALS & PHARMACEUTICALS LTD. - 524396 - Resubmiss

Pursuant to Regulation 33(3)(d) of SEBI(LODR) Regulations, 2015, the Un-audited Financial Statements of the Company for the Quarter and Half Read More

Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Announceme

Pursuant to Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed copies of Ext Read More

BIOFIL CHEMICALS & PHARMACEUTICALS LTD. - 524396 - Submissio

Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we are hereby enc Read More

BIOFIL CHEMICALS & PHARMACEUTICALS LTD. - 524396 - Board Mee

With reference to the above captioned subject, we would like to inform that Board of Directors of the Company in their meeting held on today Read More

BIOFIL CHEMICALS & PHARMACEUTICALS LTD. - 524396 - Board Mee

BIOFIL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2021 Read More

Blogs